학술논문
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
Document Type
Article
Author
Source
In: eBioMedicine . (eBioMedicine, April 2024, 102)
Subject
Language
English
ISSN
23523964